JetBlue (Nasdaq: JBLU) and Barclaycard today announced the launch of the new suite of JetBlue MasterCard credit cards, the latest complement to JetBlue’s TrueBlue loyalty program. The new JetBlue® Card features a limited-time 10,000 bonus points offer and an easy-to-earn travel rewards program. Cardmembers can earn accelerated TrueBlue points in new ways for everyday spending at restaurants and grocery stores. With the new card, cardmembers can earn award flights even faster.
“We wanted to put the award-winning JetBlue experience in our customers’ wallets,” said Jamie Perry, vice president, marketing, JetBlue. “It’s simple; customers want to earn flights more quickly. With our new card, you’re able to earn points toward your trip and get there even faster than you think.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7778051-barclaycard-jetblue-card/
NRG Energy, Inc. (NYSE:NRG), NRG Yield, Inc. (NYSE: NYLD), and SunPower Corp. (NASDAQ: SPWR) today announced the completion of the final phase of the California Valley Solar Ranch (CVSR) photovoltaic (PV) generating facility in San Luis Obispo County, California, bringing total electric generating capacity of the plant up to 250 megawatts (AC). NRG acquired CVSR from SunPower in 2011, and the project is jointly owned by NRG Yield (48.95%). CVSR is one of the world’s largest operating solar PV power plants and will sell its electricity to Pacific Gas & Electric under two long-term power purchase agreements.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64118-sunpower-nrg-energy-begin-commercial-operations-250-mw-calif-solar-ranch
Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today the launch of its Hidden ScarTM Surgery program designed to certify surgeons and establish Centers of Excellence at major cancer centers and hospitals across the country. This innovative program will train surgeons on advanced minimally invasive and minimal access surgical approaches that deliver optimal clinical and aesthetic outcomes for patients. As part of the company’s broader women’s health initiative, Invuity is hosting a Hidden Scar Breast Cancer Surgery training course in advance of the American College of Surgeons (ACS) Clinical Congress.
Invuity aims to transform the surgical treatment of breast cancer with this advanced surgical approach for nipple sparing mastectomies and lumpectomies (breast conserving surgery). Hidden Scar Breast Cancer Surgery expands surgical options for patients, offering superior cosmetic outcomes that can improve their psychological and emotional recovery and enhance quality of life after surgery.1
With growing demand for less invasive alternatives to breast cancer surgery, surgeons need to operate through smaller incisions with limited fields of vision. Invuity’s illumination technology allows surgeons to access and visualize the entire breast cavity through discrete incision locations, enabling surgeons to safely and effectively treat breast cancer while preserving the natural shape of the breast and thereby minimizing and hiding the scars.
To view the multimedia release go to:
http://www.multivu.com/players/English/7644051-invuity-hidden-scar-breast-cancer-surgery-program/
The Brown Mackie College system of schools (“Brown Mackie College”), a college of Education Management Corporation (NASDAQ:EDMC), is adopting technology into education, converting students at its 28 schools nationwide to 100 percent e-textbooks and Apple iPad technology. Through the college’s Student Advantage Program, each incoming student will receive an iPad with the applications and textbooks necessary to make the technology a key part of their overall educational experience.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59095-brown-mackie-college-system-conversion-to-e-textbooks-ipad-nationwide
Isle of Capri Casinos, Inc. (NASDAQ:ISLE) today announced the winners of its second charitable social media contest awarding a share of $50,000 to five local nonprofit organizations.
Southern Heritage Air Foundation - $25,000 – Tallulah, Louisiana
Family and Youth Opportunities Division - $15,000 – Clarksdale, Mississippi
Fayette Community Service Organization - $5,000 – Fayette, Mississippi
Guttenberg Gallery & Creativity Center - $2,500 – Guttenberg, Iowa
Walking In The Sun Rescue - $2,500 – Collinston, Louisiana
“With over 69,000 votes cast in Community Aces Challenge and over 200 applications to participate, our second charitable social media contest has proven to be a wonderful way to give back to the communities where we operate,” said Virginia McDowell, Isle’s president and chief executive officer.
“The 123 participating nonprofit organizations registered in January and coordinated their own individual voting campaigns which ended on April 1,” said McDowell. “This year the winners offered a wide variety of missions – from getting fit in rural Mississippi to enhancing creativity of young people in Iowa. Our first place winner is dedicated to educating people about the history and impact of aviation and our second place winner is refurbishing an old school to become a community center.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7805451-isle-of-capri-casinos-community-aces-challenge/
Dozens of actors, musicians, sports personalities and other distinguished guests donated their time on September 11th to honor the memories of those who lost their lives on 9/11 by raising more than $12 million for charities around the world. This special event, called Charity Day, is hosted each year by BGC Partners, Inc. (NASDAQ: BGCP) (“BGC Partners” or “BGC”), a leading global brokerage company servicing the financial and real estate markets, and its affiliates Cantor Fitzgerald and GFI Group. Celebrities who attended the event included Matthew McConaughey, Common, and Liev Schreiber in New York, and Nicole Scherzinger, Tom Hardy and Jimmy Carr in London.
In addition to the millions of dollars raised for many worthy causes, BGC Partners, Cantor Fitzgerald and GFI Group announced they are raising $5 million for the families severely impacted by Hurricanes Maria and Jose in Puerto Rico. These funds will be raised over the next several months and prepaid $1000 American Express® cash cards will be distributed to 5,000 families in January 2019.
To view the multimedia release go to:
https://www.multivu.com/players/English/8320352-bgc-partners-2018-charity-day/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
Nationally-recognized and long-standing sports announcer Jerry Punch, M.D., is teaming up with Men’s Health Network and Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), to launch “Ask About the Curve,” a new educational campaign designed to raise awareness of Peyronie’s disease. Peyronie’s disease is a little-known men’s health condition that can occur during midlife or later. And, while the disease is physical in nature, the impact may also be psychological and could possibly hold men back from talking about it.
Peyronie’s disease, or “PD,” is a condition that can cause curvature of the penis that could be painful during arousal and intimacy. It can affect as many as one in 10 men worldwide, but diagnosis rates remain low because men with PD may be too uncomfortable to speak up and get help. Together with Endo and Men’s Health Network, Dr. Punch is encouraging men who think they might have PD to face their challenge head on by starting the conversation with their doctor.
“As a sports commentator, I’ve witnessed thousands of men on the court, on the field and on the racetrack in their physical prime – cool, confident and thriving in the face of challenge. But, as a licensed physician, I’ve seen how this bravado can turn to embarrassment – even isolation – when that challenge becomes personal or intimate,” said Dr. Punch. “Often, men feel too awkward to talk about issues like Peyronie’s disease, even with a doctor. And while it may seem tough, it’s important that any man with PD see a doctor, and ask about the curve. Starting the conversation is the first step to getting help.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7752151-ask-about-the-curve-psa/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
More and more work is being done using personal mobile devices and employees expect employers to keep personal information privateMobileIron on those devices, according to new research from MobileIron (NASDAQ: MOBL). The 2015 MobileIron Trust Gap Survey, released today, examines the privacy expectations workers have when using a mobile device for work. TheMobileIron online research conducted by Harris PollMobileIron on behalf of MobileIron surveyed more than 3,500 employed adults who use a mobile device for work in France, Germany, Japan, Spain, the UK, and the US (“workers”).
“Mobile workers, especially younger workers, have an expectation of privacy when using mobile devices for work. Many would leave their jobs if their employer could see personal informationMobileIron on their device,” said Ojas Rege, Vice President, Strategy, MobileIron. “In a world where smartphones contain increasing amounts of sensitive personal data, CIOs must remember that every device is a mixed-use device and must protect employee privacy as fiercely as corporate security.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423152-mobileiron-survey-mobile-device-privacy/
SunPower Corp. (Nasdaq: SPWR) announced today that the third-generation SunPower® Oasis® platform for large-scale solar power plants, featuring a seamless integration of hardware and software unprecedented in the solar industry, is launching at an event today at SunPower’s new research and development facility in Davis, Calif.
“The Oasis platform is a complete solution that optimizes energy production and maximizes value for our power plant customers,” said Tom Werner, president and CEO of SunPower. “Integral to each Oasis component, from the automated design tools to robotic panel cleaning, is more than 30 years of solar industry innovation and experience that only SunPower offers, enabling our customers to benefit from the world’s most efficient, reliable solar technology available.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7706153-sunpower-oasis/
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the international launch of the new PicoWay™ picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, The Netherlands, October 8-12, 2014. PicoWay is a state-of-the-art dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes proprietary PicoWay technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. The staged launch of PicoWay begins in the international market during October 2014 and will continue in the United States in the first half of 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762556-syneron-launch-picoway-picosecond/
